Creating, facilitating, and promoting sustainable Health Technology Assessment (HTA) cooperation in Europe

Early Dialogues

Submission & Methodology

Assessments

National Implementation

News and Publications

OTCA22 – Final Assessment Report and related documents now available

By admin / December 12, 2019

November 2019 Implementation Report – Now Available

By admin / December 9, 2019

PTJA06 – “Polatuzumab vedotin in combination with bendamustine and rituximab for the treatment of relapsed/refractory diffuse large B-cell lymphoma (DLBCL)” final project plan now available.

By admin / November 22, 2019

$PTJA06 – “Polatuzumab vedotin in combination with bendamustine and rituximab for the treatment of relapsed/refractory diffuse large B-cell lymphoma (DLBCL)” final project plan now available.$

OTCA17 – Final Assessment Report and related documents now available

By admin / November 22, 2019

OTCA23 Final Project Plan and related documents now available

By admin / November 21, 2019

OTCA22 – Final Assessment Report and related documents now available

The final assessment report and related documents for the Other Technologies Collaborative

Learn more
November 2019 Implementation Report – Now Available

EUnetHTA is pleased to announce the new Implementation Report with Appendices are

Learn more

Services

Submission Guidelines

Submit a Pharmaceutical or Other Technology

Early Dialogues

Parallel scientific advice with the European Medical Agency (EMA)

Horizon Scanning

Topic identification, selection and prioritisation for HTA cooperation

Assessments

Assessments REA (2016-2020)

National Uptake and Case Studies

Assessments Archive (2006 - 2015)

Assessment FAQ

Tools

HTA Core Model®

Framework for shared production and sharing of HTA information

Methodology

Assistance for assessors of evidence to process, analyse and interpret the data

POP Database

Share and find information with HTA agencies on planned and ongoing events

EVIDENT Database

Share and find information on evidence gaps and studies arising from HTA

DOICU

Find process information and guidance on Conflict of Interest

Companion Guide

Repository of quality management processes and products

Creating, facilitating, and promoting sustainable Health Technology Assessment (HTA) cooperation in Europe

Early Dialogues

Submission & Methodology

Assessments

National Implementation

News and Publications

OTCA22 – Final Assessment Report and related documents now available

November 2019 Implementation Report – Now Available

PTJA06 – “Polatuzumab vedotin in combination with bendamustine and rituximab for the treatment of relapsed/refractory diffuse large B-cell lymphoma (DLBCL)” final project plan now available.

OTCA17 – Final Assessment Report and related documents now available

OTCA23 Final Project Plan and related documents now available

Services

Submission Guidelines

Early Dialogues

Horizon Scanning

Assessments

Assessments REA (2016-2020)

National Uptake and Case Studies

Assessments Archive (2006 - 2015)

Assessment FAQ

Tools

HTA Core Model®

Methodology

POP Database

EVIDENT Database

DOICU

Companion Guide

Have Questions? Check our FAQ

OUR NETWORK

CAREERS

HELP

CONTACT US

Subscribe to EUnetHTA Magazine